Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christina M. Salerno"'
Publikováno v:
Journal of Animal Ecology. 92:813-825
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69db4e58b57e10281f0fea99a4f1e71d
https://doi.org/10.1111/1365-2656.13891
https://doi.org/10.1111/1365-2656.13891
Publikováno v:
Animal Behaviour. 195:67-75
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f51266d2484704bea9d751b3a958aa06
https://doi.org/10.1016/j.anbehav.2022.10.012
https://doi.org/10.1016/j.anbehav.2022.10.012
Autor:
Barry M, Massie, Christopher M, O'Connor, Marco, Metra, Piotr, Ponikowski, John R, Teerlink, Gad, Cotter, Beth Davison, Weatherley, John G F, Cleland, Michael M, Givertz, Adriaan, Voors, Paul, DeLucca, George A, Mansoor, Christina M, Salerno, Daniel M, Bloomfield, Howard C, Dittrich, Ronald, Zolty
Publikováno v:
New England Journal of Medicine. 363:1419-1428
Worsening renal function, which is associated with adverse outcomes, often develops in patients with acute heart failure. Experimental and clinical studies suggest that counterregulatory responses mediated by adenosine may be involved. We tested the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcfdb6d04eff72b872ec6079943d7859
https://doi.org/10.1056/nejmoa0912613
https://doi.org/10.1056/nejmoa0912613
Publikováno v:
J Clin Hypertens (Greenwich)
Patients with severe hypertension are at high risk for cardiovascular events. The authors hypothesized that initial treatment with a combination angiotensin receptor blocker/diuretic agent would be safe and more effective than initial treatment with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebc262af26e682e520412b1d70ddad64
https://doi.org/10.1111/j.1524-6175.2004.03808.x
https://doi.org/10.1111/j.1524-6175.2004.03808.x
Publikováno v:
Clinical therapeutics. 18(6)
Blockade of angiotensin II receptors was first achieved in the 1970s using a peptide, saralasin acetate. Although it was effective in lowering blood pressure, it required parenteral administration and had a short duration of action and partial agonis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99d108bde900367ccaa30ba2ef4e8e56
https://pubmed.ncbi.nlm.nih.gov/9001823
https://pubmed.ncbi.nlm.nih.gov/9001823
Autor:
Christina M. Salerno, Peter Di Battiste, Steve Snapinn, Gilbert W. Gleim, Robin Mukherjee, Laura A. Demopoulos
Publikováno v:
American Journal of Hypertension. 17:S55
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ddbde9ce9ef1cf9bbb63ff2c2b7b993
https://doi.org/10.1016/j.amjhyper.2004.03.139
https://doi.org/10.1016/j.amjhyper.2004.03.139
Publikováno v:
American Journal of Hypertension. 15:A115
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::899884f21777c6883d9b17ac70921cd9
https://doi.org/10.1016/s0895-7061(02)02586-4
https://doi.org/10.1016/s0895-7061(02)02586-4
Autor:
Barry M. Massie, Denise Wolko, Michael R. Zile, Peter E. Carson, Michael M. Givertz, Piotr Ponikowski, Ileana L. Piña, Marco Metra, Christopher M. O'Connor, Scott C. Thomson, David H. Lovett, Alan B. Miller, George A. Mansoor, Paul J. Hauptman, Gad Cotter, Beth A. Davison, Jay P. Mohr, Paul DeLucca, Howard C. Dittrich, Adriaan A. Voors, John G.F. Cleland, John R. Teerlink, Christina M. Salerno, Vicente J. Iragui, Paul D. Varosy
Publikováno v:
ResearcherID
Drug Safety, 35(3), 233-244. ADIS INT LTD
Drug Safety, 35(3), 233-244. ADIS INT LTD
Background: Adenosine exerts actions in multiple organ systems, and adenosine receptors are a therapeutic target in many development programmes.Objective: The aim of this analysis was to evaluate the safety of rolofylline, an adenosine A(1)-receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0a079bd3c3c8c8996569748a476911d
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000301618100005&KeyUID=WOS:000301618100005
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000301618100005&KeyUID=WOS:000301618100005
